RPLP0P7

Across TCGA pan-cancer cohorts, RPLP0P7 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RPLP0P7 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RPLP0P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPLP0P7 expression acts as an unfavorable survival marker, although some lineages such as BLCA and READ show a favorable association.

KIRP, THYM, and ACC are the cancer types where RPLP0P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.489	0.888	<.001	132	view →
THYM	OS	Tertile	All	0.743	1.000	<.001	60	view →
ACC	OS	Tertile	All	0.503	0.843	.005	57	view →
MESO	OS	Tertile	IV	0.155	0.624	.004	54	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
BLCA	OS	Tertile	All	0.808	0.405	.009	36	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
UVM	OS	Tertile	III,IV	0.461	0.835	.024	18	view →
ESCA	OS	Quartile	All	0.436	1.000	.002	18	view →
READ	DFS	Median	III,IV	0.850	0.673	.016	13	view →
STAD	OS	Quartile	All	0.613	0.732	.022	9	view →
OV	OS	Tertile	III,IV	0.268	0.357	.032	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RPLP0P7–KIRP (OS)

Open the KIRP breakdown →